Financhill
Sell
47

CGTX Quote, Financials, Valuation and Earnings

Last price:
$0.43
Seasonality move :
-22.26%
Day range:
$0.42 - $0.47
52-week range:
$0.31 - $2.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.44x
Volume:
484.2K
Avg. volume:
524.6K
1-year change:
-77.47%
Market cap:
$26.9M
Revenue:
--
EPS (TTM):
-$0.87

Earnings Data

Next earnings date for CGTX
May 07
2025
Most recent earnings per share
-$0.17
Missed by $0.02
(Mar 20/2025)
Consensus Estimate
-$0.15
(Mar 20/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CGTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 -- -- -- -$0.10 --
05/07/2025 Q1 -- -- -- -$0.12 --
03/20/2025 Q4 -- -- -$0.17 -$0.15 -$0.02
11/13/2024 Q3 -- -- -$0.25 -$0.21 -$0.04
08/08/2024 Q2 -- -- -$0.18 -$0.23 $0.05
05/07/2024 Q1 -- -- -$0.27 -$0.25 -$0.03
03/26/2024 Q4 -- -- -$0.27 -$0.33 $0.06
11/02/2023 Q3 -- -- -$0.22 -$0.29 $0.07
08/08/2023 Q2 -- -- -$0.16 -$0.21 $0.05
05/04/2023 Q1 -- -- -$0.21 -$0.18 -$0.04
03/23/2023 Q4 -- -- -$0.20 -$0.30 $0.10
11/14/2022 Q3 -- -- -$0.29 -- --
08/09/2022 Q2 -- -- -$0.25 -- --
05/11/2022 Q1 -- -- -$0.17 -- --
03/30/2022 Q4 -- -- -$0.34 -- --
11/17/2021 Q3 -- -- -$0.24 -- --
06/30/2021 Q2 -- -- -$0.14 -- --
03/31/2021 Q1 -- -- -$0.04 -- --
12/31/2020 Q4 -- -- -$0.14 -- --
09/30/2020 Q3 -- -- -$0.13 -- --
06/30/2020 Q2 -- -- -$0.17 -- --
03/31/2020 Q1 -- -- -$0.12 -- --

Cognition Therapeutics Earnings Questions

  • How Much did Cognition Therapeutics Generate in Revenue Last Quarter?

    Cognition Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Cognition Therapeutics Beat Earnings Last Quarter?

    Cognition Therapeutics announced earnings per share of -$0.17 which represents a miss of analyst forecast a -$0.15 per share.

  • Is Cognition Therapeutics Profitable?

    Cognition Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Cognition Therapeutics EPS Next Year?

    Cognition Therapeutics's earnings are forecast to decrease from -$0.86 per share to -$0.79 per share next year representing a decrease of -53.49%.

  • When is Cognition Therapeutics's Earnings Date?

    Cognition Therapeutics's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Is RTX The Best Growth Stock?
Is RTX The Best Growth Stock?

Among the worldwide aerospace and defense markets, the US controls…

Is VFS Stock Cheap to Buy Now?
Is VFS Stock Cheap to Buy Now?

VinFast Auto (NASDAQ:VFS) is a leading EV manufacturer in Vietnam.…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
86
TRUP alert for May 6

Trupanion [TRUP] is down 0.38% over the past day.

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 53.44% over the past day.

Sell
35
XYZ alert for May 6

Block [XYZ] is up 0.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock